Status:
COMPLETED
Validation of EPIC's Readmission Risk Model, the LACE+ Index and SQLape as Predictors of Unplanned Hospital Readmissions
Lead Sponsor:
Luzerner Kantonsspital
Collaborating Sponsors:
Universität Luzern
Conditions:
Hospital Readmission
Eligibility:
All Genders
1-100 years
Brief Summary
The primary objective of this study is to externally validate the EPIC's Readmission Risk model and to compare it with the LACE+ index and the SQLape Readmission model. As secondary objective, the EP...
Detailed Description
Introduction: Readmissions after an acute care hospitalization are relatively common, costly to the health care system and are associated with significant burden for patients. As one way to reduce cos...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- \- All inpatients, aged one year or older (max. 100 years), who were hospitalized either between the 1st of January 2018 and the 31st of December 2018, or between the 23rd of September and the 31st of December 2019 will be included.
- Exclusion criteria:
- admission/transfer from another psychiatric, rehabilitative or acute care ward from the same institution,
- discharge destination other than the patient's home or
- transfer to another acute care hospital, both being considered as treatment continuation;
- foreign residence,
- deceased before discharge,
- discharged on admission day,
- refusal of general consent, and
- unknown patient residence or discharge destination.
Exclusion
Key Trial Info
Start Date :
March 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2020
Estimated Enrollment :
23116 Patients enrolled
Trial Details
Trial ID
NCT04306172
Start Date
March 10 2020
End Date
October 1 2020
Last Update
October 20 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cantonal Hospital of Lucerne
Lucerne, Canton Lucerne, Switzerland, 6000